Phase II Trial of Caelyx and Cyclophosphamide in Metastatic Breast Cancer.

Next Previous
Trial Profile

Phase II Trial of Caelyx and Cyclophosphamide in Metastatic Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Cyclophosphamide
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme

    • Most Recent Events

    • 06 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top